Skip to main content
. 2011 Sep 28;73(3):467–477. doi: 10.1111/j.1365-2125.2011.04103.x

Figure 3.

Figure 3

Combined drug exposure of ARS and DHA to illustrate antimalarial effect concentrations in pregnant women treated with intravenous and oral artesunate who were mildly or moderately unwell with uncomplicated malaria